Avastin is a vascular endothelial growth factor-specific angiogenesis
inhibitor indicated for the treatment of:
• Covid19 Studies going on to treat for Covid19 Patients. • Colorectal cancer Bevacizumab was approved in the United States in February 2004, for use in metastatic colorectal cancer. • Lung cancer In 2006, the U.S. Food and Drug Administration (FDA) approved bevacizumab for use in first-line advanced nonsquamous non-small cell lung cancer in combination with carboplatin/paclitaxel chemotherapy. • Breast cancer In December 2010, the U.S. Food and Drug Administration (FDA) notified its intention to remove the breast cancer indication from bevacizumab. • Renal cancers In 2009, the FDA approved bevacizumab for use in metastatic renal cell cancer (a form of kidney cancer). EU approval was granted in 2007. In the EU, bevacizumab in combination with interferon alfa-2a is indicated for first-line treatment of adults with advanced and/or metastatic renal cell cancer. • Brain cancers The FDA granted accelerated approval for the treatment of recurrent glioblastoma multiforme in May 2009. • Eye disease Many diseases of the eye, such as age-related macular degeneration (AMD) and diabetic retinopathy, damage the retina and cause blindness when blood vessels around the retina grow abnormally and leak fluid, causing the layers of the retina to separate. This abnormal growth is caused by VEGF, so bevacizumab has been successfully used to inhibit VEGF and slow this growth. • Ovarian cancer In 2018, the U.S. Food and Drug Administration (FDA) approved bevacizumab in combination with chemotherapy for stage III or IV of ovarian cancer after initial surgical operation, followed by single-agent bevacizumab. • Cervical cancer In the EU, bevacizumab, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in people who cannot receive platinum therapy, is indicated for the treatment of adults with persistent, recurrent, or metastatic carcinoma of the cervix.
Brand Name "Bevacizumab injection" medication can be imported and made available on "Named Patient Program (NPP)" treatment in Philippines, Vietnam, Ireland, UK, Europe, Middle Eastern countries, and India. Please contact at +91 9910645395 (Mr. Rakesh) or make an enquiry at info@cancermedicinesnetwork to find the cost price to buy "Bevacizumab injection" online and have it delivered where you live. We take guarantee of quality and delivery as per the buyer’s requirements.
Dear Rakesh and Colleagues,
We are very happy to let you know that, just after three weeks, there is no trace of the sickness anymore: your medicine did the job very well!
We will always remember with great pleasure your warm welcoming in Delhi! We would like to thank you very much and wish you all the best. In the coming future we will be delighted to suggest your company to other patients.
Sir, As a first time buyer of an iported drug I'm imressed with your company in procurement of the drug from Canada through the shipping time of 11 to 12 days is quite long to wait. Mr Rajesh Kanan your coordinator has been very helpful and cooperative to my many queries. He is always responsive to my SMS, Whatsapp, email and phone calls. Hoping that the good trend will continue in the future. There is some miscommunications with the TNT courier with my first delivery. Hope that will be solved in the second delivery.
Patient, Physcian, distributor/supplier can buy and import Brand Name "Bevacizumab injection" from Verve Biosciences, if the drug has not been approved or is not available in your country. Make an enquiry and we will help you calculate the total price to buy "Bevacizumab injection" online and have it delivered where you live. From your side, we’ll simply need a prescription from your treating doctor. In some countries we might also need an import license. Our Patient Support team will guide you throughout the process.
Verve Biosciences facilitates import of anti-cancer medicines Bevacizumab injection, Make an enquiry to find the total cost of Bevacizumab injection in UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.